Medicare Enrolled
Dr. Kaupin Brahmbhatt, M.D.
Optician · Roslyn, NY
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brahmbhatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brahmbhatt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brahmbhatt
Dr. Kaupin Brahmbhatt is an optician specialist in Roslyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brahmbhatt performed 5,981 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Brahmbhatt received a total of $11,414 from 37 pharmaceutical and/or device companies across 549 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brahmbhatt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in NY
$11,414 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,981
Medicare services
Top 12% in NY for optician
Not available
Unique patients (not deduplicated)
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,129 | $13 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,126 | $110 | $438 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
867 | $111 | $406 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
644 | $44 | $162 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
514 | $97 | $349 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
339 | $144 | $692 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
298 | $186 | $689 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
268 | $58 | $246 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
267 | $413 | $1,565 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
235 | $160 | $591 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
111 | $74 | $270 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $143 | $532 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
27 | $56 | $259 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
21 | $49 | $178 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
21 | $23 | $84 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
21 | $219 | $817 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $58 | $226 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.0% high complexity
34.0% medium
60.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,414
Total received (2018-2024)
Avg $1,631/year across 7 years
Top 13% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
549
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,406
2023
$2,411
2022
$2,576
2021
$1,629
2020
$652
2019
$1,068
2018
$672
Payments by company (2024)
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Novartis Pharmaceuticals Corporation
$231
PFIZER INC.
$229
E.R. Squibb & Sons, L.L.C.
$224
Amgen Inc.
$174
Novo Nordisk Inc
$154
Daiichi Sankyo Inc.
$142
Lexicon Pharmaceuticals, Inc.
$138
Janssen Pharmaceuticals, Inc
$126
Merck Sharp & Dohme LLC
$112
SANOFI-AVENTIS U.S. LLC
$110
Esperion Therapeutics, Inc.
$90
Boston Scientific Corporation
$80
AstraZeneca Pharmaceuticals LP
$78
Abbott Laboratories
$70
SCPHARMACEUTICALS INC.
$69
HEARTFLOW, INC.
$53
Kiniksa Pharmaceuticals International, plc
$25
Regeneron Healthcare Solutions, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$20
Chiesi USA, Inc.
$15
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,158
AstraZeneca Pharmaceuticals LP
$946
Boehringer Ingelheim Pharmaceuticals, Inc.
$899
Amgen Inc.
$855
SANOFI-AVENTIS U.S. LLC
$836
Abbott Laboratories
$672
PFIZER INC.
$622
Bayer HealthCare Pharmaceuticals Inc.
$603
Merck Sharp & Dohme LLC
$545
E.R. Squibb & Sons, L.L.C.
$491
Esperion Therapeutics, Inc.
$463
Janssen Pharmaceuticals, Inc
$419
Novo Nordisk Inc
$359
Boston Scientific Corporation
$327
Regeneron Healthcare Solutions, Inc.
$319
NOVARTIS PHARMACEUTICALS CORPORATION
$285
Lexicon Pharmaceuticals, Inc.
$231
Kowa Pharmaceuticals America, Inc.
$181
Daiichi Sankyo Inc.
$172
Althera Pharmaceuticals LLC
$113
BOSTON SCIENTIFIC CORPORATION
$110
Kestra Medical Technology Services, Inc.
$84
Impulse Dynamics (USA) Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$71
SCPHARMACEUTICALS INC.
$69
Astellas Pharma US Inc
$66
Gilead Sciences, Inc.
$64
Allergan Inc.
$63
Relypsa, Inc.
$57
HEARTFLOW, INC.
$53
Merck Sharp & Dohme Corporation
$43
Kiniksa Pharmaceuticals, Ltd.
$38
Lundbeck LLC
$34
Chiesi USA, Inc.
$34
Kiniksa Pharmaceuticals International, plc
$25
ARBOR PHARMACEUTICALS, INC.
$18
CHIESI USA, INC.
$13
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ASSURITY · AVEIR · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CLEVIPREX · CardioMEMS HF System · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbyclor · FARXIGA · FFRct · FUROSCIX · INJECTAFER · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LOKELMA · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · Ranexa · Repatha · Roszet · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Veltassa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
16,372
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
ST FRANCIS HOSPITAL - THE HEART CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brahmbhatt is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 12% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brahmbhatt experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Brahmbhatt performed 1,129 electrocardiogram (ekg), 12-lead services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Brahmbhatt receive payments from pharmaceutical companies?
Yes. Dr. Brahmbhatt received a total of $11,414 from 37 companies across 549 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brahmbhatt's costs compare to other opticians in Roslyn?
Dr. Brahmbhatt's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brahmbhatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Roslyn
Browse opticians in Roslyn ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology